Monday, April 29, 2024
Advertise Here
HomeNews DeskRecall of Extended Release Metformin

Recall of Extended Release Metformin

On October 10th, 2020 the FDA sent out an alert informing partners and health care professionals of the recall of Extended-Release (ER) Metformin (a popular drug used to treat diabetes and Polycystic Ovary Syndrome) distributed by Marksans Pharma and Sun Pharmaceutical Industries.

The companies are recalling this Metformin because it contains N-Nitrosodimethylamine (NDMA), a probable human carcinogenic- which is at an unacceptably high level in the drug. Metformin from the specific manufacturer Marksans Pharma, being sold under brand name Time-Cap Tabs Inc., is the Metformin which has been recalled.

An investigation was launched by the Ministry of Health, Wellness and New Health Investment and we can now reassure the general public that the Metformin being recalled, Extended Release (ER) Metformin brand name Time Cap Tabs Inc., is neither procured by the Ministry of Health nor sold in the established pharmacies in Dominica.

Therefore we wish to encourage our diabetics and other members of the population using Metformin to continue taking your medication as prescribed and to continue with all other diabetic management guidelines you have been given from your health care professionals.

RELATED ARTICLES